-
Dr Tarantino on the Evolving Role of THP in HER2+ Metastatic Breast Cancer
19 Jun 2025 19:31 GMT
… the evolving role of trastuzumab (Herceptin) plus pertuzumab (Perjeta), and a … (THP) in HER2-positive metastatic breast cancer following the readout of data …
-
Ananda Lewis, Former MTV VJ Who Had Breast Cancer, Dies at 52
18 Jun 2025 22:41 GMT
… Breast Cancer. It reads in part: What is breast cancer? … How is breast cancer classified? Breast cancer usually arises in … it expresses. Most breast tumors carry estrogen or … such as Herceptin (trastuzumab). Triple negative breast cancer (TNBC) …
-
T-DXd Plus Pertuzumab Could Add to Antibody-Drug Conjugate Arsenal in HER2+ Breast Cancer
18 Jun 2025 20:24 GMT
… HER2-positive advanced or metastatic breast cancer, excitement has continued to flourish … is a taxane plus trastuzumab [Herceptin] and pertuzumab [THP] followed by … –positive (HER2+) advanced/metastatic breast cancer (a/mBC): interim results …
-
Breast Cancer and the Use of Predictive Genomics
18 Jun 2025 16:10 GMT
… Breast Cancers
Predictive genomics in breast cancer … + breast cancer are trastuzumab (Herceptin), … breast-cancer-stat-bite.html
4. Breast cancer facts & stats. National Breast Cancer … Breast cancer cell line classification and its relevance with breast tumor …
-
Headlines — Ms Cruise, Breast Cancer & Court Ruling
18 Jun 2025 13:35 GMT
… Rights
BREAST CANCER
DRUG CUTS RECURRENCE RATE
The breast cancer medication Herceptin, made … , MD, who oversees breast cancer trials for the National … nodes. For women with breast cancer that has not spread … women are diagnosed with breast cancer each year in …
-
Understanding the Importance of the DESTINY-Breast09 Trial in HER2+ Breast Cancer
17 Jun 2025 22:09 GMT
… metastatic HER2-positive positive breast cancer,” Tolaney explained.
In … to 20% of all breast cancers are HER2-positive, and … care is a taxane plus Herceptin (trastuzumab) and Perjeta, … metastatic HER2-positive positive breast cancer.
Transcript has been …
-
Herceptin Market Report 2025 – For Strategy Officers And Market Intelligence Teams
17 Jun 2025 13:10 GMT
… regulatory approvals, rising breast cancer incidence, advancements in … herceptin market going forward is the increasing incidence of breast cancer … global-market-report
Breast Cancer Drugs Global Market … 47;report/breast-cancer-drugs-global-market-report …
-
T-DXd Plus Pertuzumab Could Redefine First-Line HER2+ Breast Cancer Management: With Paolo Tarantino, MD
11 Jun 2025 23:26 GMT
… key updates in HER2-positive breast cancer presented at the 2025 ASCO … ) vs induction taxane plus trastuzumab (Herceptin) and pertuzumab (THP) in the … patients with HER2-positive metastatic breast cancer. The T-DXd regimen produced …
-
DESTINY-Breast09 and Ongoing Trials Underscore Shifting ADC Landscape in HER2+ Breast Cancer
11 Jun 2025 16:54 GMT
… lines of HER2-positive breast cancer management, with fam … -NC) with trastuzumab (Herceptin) plus pertuzumab and a … management of HER2-positive breast cancer, particularly considering sequencing … HER2+) advanced/metastatic breast cancer (a/mBC): …
-
Dr Kalinsky on Evolving Roles for the CLEOPATRA and DESTINY-Breast09 Regimens in HER2+ Breast Cancer
11 Jun 2025 01:06 GMT
… role of pertuzumab (Perjeta), trastuzumab (Herceptin), and docetaxel (THP) from the … ) plus pertuzumab in HER2-positive breast cancer.
Interim data from DESTINY-Breast09 … the first-line, HER2-positive breast cancer treatment paradigm, Kalinsky began.
Among …